Standard BioTools Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Election of Directors: Eli Casdin

Standard BioTools Inc.’s own tally for this item (“Elect Director: Eli Casdin”): 234,717,465 for, 15,064,133 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to serve as Class I directors, to hold office until the Company's 2029 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified or their earlier resignation or removal:”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 38 asset managers below reported 43,403,755 for, 869,404 withheld, 30 abstained.

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

Description as filed by funds: Election of Directors: Michael Egholm, Ph.D.

Standard BioTools Inc.’s own tally for this item (“Elect Director: Michael Egholm, Ph.D.”): 236,313,971 for, 13,467,627 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to serve as Class I directors, to hold office until the Company's 2029 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified or their earlier resignation or removal:”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 38 asset managers below reported 44,243,274 for, 29,890 withheld, 25 abstained.

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

Description as filed by funds: Election of Directors: Thomas Carey

Standard BioTools Inc.’s own tally for this item (“Elect Director: Thomas Carey”): 227,843,498 for, 21,938,100 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to serve as Class I directors, to hold office until the Company's 2029 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified or their earlier resignation or removal:”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 38 asset managers below reported 42,653,162 for, 1,619,976 withheld, 51 abstained.

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

Description as filed by funds: To approve the Standard BioTools Inc. 2026 Equity Incentive Plan.

Standard BioTools Inc.’s own tally for this item (“4. Approval of the 2026 Equity Incentive Plan”): 228,342,854 for, 17,821,911 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve the 2026 Plan was approved by the following votes:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 39,988,421 for, 772,248 against, 3,582,648 abstained.

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

Description as filed by funds: TO APPROVE AN AMENDMENT TO OUR AMENDED AND RESTATED 2017 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE THEREUNDER BY 1,200,000 SHARES.

Standard BioTools Inc.’s own tally for this item (“5. Approval of the Amendment to the Amended and Restated 2017 Employee Stock Purchase Plan”): 237,474,844 for, 12,276,507 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve the amendment to the ESPP to increase the shares of common stock reserved thereunder by 1,200,000 shares was approved by the following votes:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 38 asset managers below reported 44,273,166 for, 22 against.

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement.

Standard BioTools Inc.’s own tally for this item (“2. Advisory Vote on Approval of Executive Compensation”): 209,778,412 for, 36,318,595 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve, on an advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2025 was approved by the following votes:”
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 37 managers: 29,325,360 for, 11,365,181 against, 3,582,648 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 122 managers: 169,759,430 for, 24,584,854 against, 67 abstained. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026.

Standard BioTools Inc.’s own tally for this item (“3. Ratification of Appointment of Independent Registered Public Accounting Firm”): 330,172,606 for, 652,236 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 was approved by the following vote:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 38 asset managers below reported 44,243,291 for, 29,891 against, 8 abstained.

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.